Home
Drugs
Irinotecan
Clinical Trials

Clinical Trials Related to Irinotecan

Related studies linked through entity extraction aliases.

An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer

Status: COMPLETED
Phase: PHASE1

An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Status: RECRUITING
Phase: PHASE2

A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma

Status: RECRUITING
Phase: PHASE2

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

Status: TERMINATED
Phase: PHASE1

Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Status: RECRUITING
Phase: PHASE3

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Status: NOT_YET_RECRUITING
Phase: PHASE3

Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC

Status: RECRUITING
Phase: PHASE3

The Sagittarius Trial

Status: RECRUITING
Phase: PHASE3

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

Status: RECRUITING
Phase: PHASE3

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Status: RECRUITING
Phase: PHASE2

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Status: RECRUITING
Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Status: NOT_YET_RECRUITING
Phase: PHASE1/PHASE2

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Status: RECRUITING
Phase: PHASE2

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Status: RECRUITING
Phase: PHASE3

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Status: RECRUITING
Phase: PHASE2